Worth reading
45Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
783000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Cancellation of the designation of suspension of exercise of the 18th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions)
発行・処分する株式数
7,830 stock acquisition rights (783,000 shares) subject to the suspension designation
Intended allottee
EVO FUND
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment provision. The adjustment floor is Not disclosed
Number of Stock Acquisition Rights
7,830 rights are subject to the suspension designation. The number of unexercised rights is Not disclosed
Most recent equity financing
Issuance of the 18th and 19th Series of Stock Acquisition Rights through a third-party allotment, announced on 18 November 2025 (detailed amount is Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Cancellation of the designation of suspension of exercise of the 18th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) |
| Number of shares to be issued or disposed of | 7,830 stock acquisition rights (783,000 shares) subject to the suspension designation |
| Intended allottee | EVO FUND |
| Exercise price | Subject to an exercise price adjustment provision. The adjustment floor is Not disclosed |
| Number of Stock Acquisition Rights | 7,830 rights are subject to the suspension designation. The number of unexercised rights is Not disclosed |
| Most recent equity financing | Issuance of the 18th and 19th Series of Stock Acquisition Rights through a third-party allotment, announced on 18 November 2025 (detailed amount is Not disclosed) |
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because, under the allotment agreement entered into with EVO FUND, the allottee, the Company notified EVO FUND of the cancellation of the designation of suspension of exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.